Dragonfly Energy Announces Corporate Debt Restructuring and Capital Raise - Dragonfly Energy Hldgs ( NASDAQ:DFLI ) , Dragonfly Energy Hldgs ( NASDAQ:DFLIW )
Debt Restructuring with Maturity Extension and Covenant Waiver Concurrent $3.5 Million Capital Raise With Second Contingent Tranche of $4.5 Million Transactions Significantly Increase Financial Flexibility and Liquidity
Amicus Therapeutics to Present at Upcoming Investor Conferences in March 2025 - Amicus Therapeutics ( NASDAQ:FOLD )
PRINCETON, N.J., Feb. 27, 2025 ( GLOBE NEWSWIRE ) -- Amicus Therapeutics FOLD today announced that management will participate in upcoming presentations at the following investor conferences in March. TD Cowen 45th Annual Health Care Conference in Boston, MA, on Tuesday, March 4, 2025, at ...
Sotera Health Reports Fourth-Quarter and Full-Year 2024 Results; Provides 2025 Outlook
CLEVELAND, Feb. 27, 2025 ( GLOBE NEWSWIRE ) -- Sotera Health Company ( "Sotera Health" or the "Company" ) ( Nasdaq: SHC ) , a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services for the healthcare industry, today announced financial ...
Stella-Jones Announces Fourth Quarter and Year-End Results
Annual sales of $3,469 million, up 5% vs the prior year EBITDA ( 1 ) of $633 million, or 18.2% margin ( 1 ) Strong operating cash flow of $408 million Increasing quarterly dividend by 11% to $0.31 per share MONTREAL, Feb. 27, 2025 ( GLOBE NEWSWIRE ) -- Stella-Jones Inc.
Atea Pharmaceuticals to Host Fourth Quarter and Full Year 2024 Financial Results Conference Call on March 6, 2025 - Atea Pharmaceuticals ( NASDAQ:AVIR )
BOSTON, Feb. 27, 2025 ( GLOBE NEWSWIRE ) -- Atea Pharmaceuticals, Inc. AVIR ( "Atea" ) , a clinical-stage biopharmaceutical company engaged in the discovery and development of oral antiviral therapeutics for serious viral diseases, today announced that it will host a live conference call and ...
GH Research Reports Full Year 2024 Financial Results and Provides Business Updates - GH Research ( NASDAQ:GHRS )
Phase 2b clinical trial of GH001 in patients with treatment-resistant depression on track for completion of last patient visit in the open-label extension in Q1 2025 Phase 1 clinical trial to evaluate proprietary aerosol delivery device in healthy volunteers is ongoing in the UK
Aduro Clean Technologies Appoints Vice President of Finance
Aduro Clean Technologies appoints Neha Nisar as VP of Finance to support growth and scale operations following its Nasdaq uplisting.
uniQure Announces 2024 Financial Results and Highlights Recent Company Progress
~ Announced alignment with the U.S. Food and Drug Administration ( FDA ) on key elements of the Accelerated Approval pathway for AMT-130 in Huntington's disease. Initiated preparations for a potential Biologics License Application ( BLA ) submission ...
Aduro Clean Technologies Appoints Vice President of Finance - Aduro Clean Technologies ( NASDAQ:ADUR )
LONDON, Ontario, Feb. 27, 2025 ( GLOBE NEWSWIRE ) -- Aduro Clean Technologies Inc. ( "Aduro" or the "Company" ) ADUR ( CSE: ACT ) 9D5, a clean technology company using the power of chemistry to transform lower value feedstocks, like waste plastics, heavy bitumen, and renewable oils, into ...
Macerich Reports Fourth Quarter 2024 Results
SANTA MONICA, Calif., Feb. 27, 2025 ( GLOBE NEWSWIRE ) -- The Macerich Company ( NYSE: MAC ) has released its Fourth Quarter 2024 Earnings Results and Supplemental Information by posting it to the Investor Relations section of its website at investing.macerich.com.
